本期内容提示:
1、一大波核心仓位出现建仓机会,优先考虑哪些?
2、又一只有翻倍潜力的成长股临近理想建仓区;
3、$Rxi Pharmaceuticals Corp(PHIO)$ 数据不错,可否追涨?
$恒瑞医药(SH600276)$ $华东医药(SZ000963)$查看全文
Replix锐璞美股2021-03-01 21:16
$Phio Pharmaceuticals(PHIO)$ PHIO PHARMACEUTICALS AND AGONOX, INC. ANNOUNCE COLLABORATION ON CLINICAL DEVELOPMENT OF NOVEL T CELL-BASED CANCER IMMUNOTHERAPIES
Under the terms of the collaboration agreement, AgonOx will receive financial support for the clinical trial from...查看全文
Replix锐璞美股2021-02-18 14:08
$Phio Pharmaceuticals(PHIO)$ 公司增发完毕,看看是否能翻身。
$基因进化ETF-ARK(ARKG)$ $富途控股(FUTU)$查看全文
$Phio Pharmaceuticals(PHIO)$ ARS Annual Report to Security Holders Accession Number: 0001683168-23-004047 Act: 34 Size: 1 MB 网页链接
$Phio Pharmaceuticals(PHIO)$ S-1 General form for registration of securities under the Securities Act of 1933 Accession Number: 0001683168-23-004016 Act: 33 Size: 582 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 1.01, 3.02, 8.01, and 9.01 Accession Number: 0001683168-23-003863 Act: 34 Size: 1 MB 网页链接
$Phio Pharmaceuticals(PHIO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001683168-23-003815 Act: 33 Size: 369 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001683168-23-003671 Act: 34 Size: 221 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001683168-23-003433 Act: 34 Size: 218 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001683168-23-003213 Act: 34 Size: 3 MB 网页链接
$Phio Pharmaceuticals(PHIO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001683168-23-003214 Act: 34 Size: 251 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001683168-23-003127 Act: 33 Size: 141 KB 网页链接
$Phio Pharmaceuticals(PHIO)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-001352 Act: 33 Size: 1 KB 网页链接